Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study-Reference-Cited by-同舟云学术

Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study

Published:2004-07 Issue:1 Volume:79 Page:21-27
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Koh Hui-Hiang,Murray Ian J.,Nolan Daniel,Carden Dave,Feather Jim,Beatty Stephen

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference29 articles.

1. A randomized, placebo-controlled, clinical trial of high-dose supplementation with Vitamins C and E, beta carotene, and Zinc for age-related macular degeneration and vision loss. AREDS Report No. 8;Arch. Ophthalmol.,2001

2. Macular pigment and age-related macular degeneration;Beatty;Br. J. Ophthalmol.,1999

3. Macular pigment optical density measurement; a novel compact instrument;Beatty;Ophthalmic. Physiol. Opt.,2000

4. The role of oxidative stress in the pathogenesis of age-related macular degeneration;Beatty;Surv. Ophthalmol.,2000

5. The putative protective role of macular pigment for age-related macular degeneration and the potential benefits of supplemental lutein and zeaxanthin;Beatty;CME-Ophtalmol.,2000

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Xanthophyll pigments dietary supplements administration and retinal health in the context of increasing life expectancy trend;Frontiers in Nutrition;2023-08-10

2. Can Nutrition Play a Role in Ameliorating Digital Eye Strain?;Nutrients;2022-09-27

3. The level and efficacy of lutein in patients with age-related macular degeneration: a comprehensive systematic review and meta-analysis;Annals of Translational Medicine;2022-03

4. Assessment of dietary carotenoid intake and biologic measurement of exposure in humans;Methods in Enzymology;2022

5. Phytotherapeutic and Natural Compound Applications for Age-Related, Inflammatory and Serious Eye Ailments;Current Molecular Pharmacology;2021-12-16